|
BCG Vaccine (Freeze Dried)
Live attenuated strains of Mycobacterium bovis (Bacillus Calmette Guerin) Between 2 X 100000 and 8 X 100000 CFU/0.1 ml,Monosodium Glutamate 0.75 mg per 0.1 ml of the reconstituted product mg/ mL
|
live, freeze-dried vaccine
|
Tanzania
|
TAN 23 V 0122
|
Registered/Compliant
|
|
BIVALENT POLIOMYELITIS VACCINE
MONOVALENT BULK OF POLIOMYELITIS VACCINE ;BIVALENT TYPE 1 & 3
|
EACH DOSE OF 2 DROPS (0.1 ML) CONTAINS POLIO VIRUS (SABIN), GROWN ON PRIMARY MONKEY KIDNEY CULTURE:POLIO VIRUS (SABIN)TYPE 1 ? 106 CCID50
|
Kenya
|
CTD 4142
|
Registered
|
|
BIVALENT POLIOMYELITIS VACCINE
MONOVALENT BULK OF POLIOMYELITIS VACCINE ;BIVALENT TYPE 1 & 3
|
EACH DOSE OF 2 DROPS (0.1 ML) CONTAINS POLIO VIRUS (SABIN), GROWN ON PRIMARY MONKEY KIDNEY CULTURE:POLIO VIRUS (SABIN)TYPE 1 ? 106 CCID50
|
Kenya
|
CTD4142
|
Registered
|
|
CYVAC 1 Dose
R21 Malaria Antigen 5 mcg
|
Solution for injection
|
Tanzania
|
TAN 24 V 0131
|
Registered/Compliant
|
|
CYVAC 2 Dose
R21 Malaria Antigen 5mcg mcg
|
Solution for injection
|
Tanzania
|
TAN 24 V 0132
|
Registered/Compliant
|
|
DIPHTHERIA AND TETANUS VACCINE ADSORBED
1. PURIFIED DIPHTHERIA TOXOID 2. PURIFIED TETANUS TOXOID
|
EACH SINGLE 0.5 ML HUMAN DOSE CONTAINS DIPHTHERIA TOXOID 5 LF ( 2 IU) TETANUS TOXOID 5 LF ( 40 IU)
|
Kenya
|
CTD 4047
|
Registered
|
|
DTPHH
Adsorbed on Aluminium Phosphate, Al+++ ≤ 1.25 mg/0.5ml,B. pertussis (whole cell) ≤ 16 OU (≥ 4 IU) IOU,Bulk Purified Tetanus Toxoid ≥ 2.5 Lf (≥ 40 IU) LF,Diphtheria Toxoid ≤ 25 Lf (≥ 30 IU) LF,Purified HBsAg ≥ 10 mcg/0.5ml,Purified capsular Hib Polysaccharide (PRP) Conjugated to Tetanus Toxoid (carrier protein) 10 mcg/0.5ml,Thiomersal 0.005 %
|
Suspension for injection
|
Tanzania
|
TZ13H210
|
Registered/Compliant
|
|
DTPHH Vaccine
Adsorbed on Aluminium Phosphate, Al+++ ≤ 1.25 mg/0.5ml,B. pertussis (whole cell) ≤ 16 OU (≥ 4 IU) IOU,Diphtheria Toxoid ≤ 25 Lf (≥ 30 IU) LF,Purified HBsAg ≥ 10 mcg/0.5ml,Purified Tetanus Toxoid ≥ 2.5 Lf (≥ 40 IU) Lf/0.5ml,Purified capsular Hib Polysaccharide (PRP) Conjugated to Tetanus Toxoid (carrier protein) 10 mcg/0.5ml,Thiomersal 0.005 %
|
Suspension for injection
|
Tanzania
|
TZ13H211
|
Registered/Compliant
|
|
Hepatitis B Vaccine (rDNA) (Paediatric)
Aluminium hydroxide gel. 0.25 mg to 0.40 mg mg,Purified Hepatitis B surface antigen(HBsAg) 10 mcg/0.5ml,Thiomersal (as preservative) 0.005 %
|
Suspension for injection
|
Tanzania
|
TAN 24 V 0039
|
Registered/Compliant
|
|
Hepatitis B Vaccine r-DNA, Adult
Hepatitis B Surface Antigen Aqueous 20 mcg/ml
|
Suspension for injection
20
|
Tanzania
|
TAN 05,684 J07A SER
|
Registered/Compliant
|
|
Hepatitis B Vaccine r-DNA, Paediatric
Hepatitis B Surface Antigen Aqueous 10 mcg/ml
|
Suspension for injection
|
Tanzania
|
TAN 05,682 J07A SER
|
Registered/Compliant
|
|
Measles & Rubella Vaccine Live, Attenuated (Freeze dried)
L - Arginine Hydrochloride 1.60 %,L histidine 0.21 %,L-Alanine 0.1 %,Lactalbumin hydrolysate 0.35 %,Measles Virus 1000 CCID50/dose,Minimum Essensial Medium (MEM) QS QS,Partially hydrolysed gelatin 2.5 %,Rubella Virus 1000 CCID50/dose,Sorbitol 5 %,Tricine 0.3 %
|
Injection
|
Tanzania
|
TZ14H019
|
Registered/Compliant
|
|
Measles & Rubella Virus Vaccine Live U.S.P 10 doses
Anhydrous Disodium hydrogen Phosphate g/g,Disodium Edetate g/g,L - Arginine Hydrochloride g/g,Lactalbumin hydrolysate g/g,Measles Virus mg/4ml,Measles Virus 1x10000 mg/4ml,Minimum Essensial Medium (MEM) g/g,Mumps Virus 12.5 x 10000 mg/4ml,Rubella Virus mg/4ml,Rubella Virus 1 x 10000 mg/4ml,Tricine g/g
|
Injection
|
Tanzania
|
TZ14H019
|
Registered/Compliant
|
|
Measles Mumps and Rubella Vaccine Live, Attenuated (Freeze-Dried) 1 dose
L - Arginine Hydrochloride 1.60 %,L-Alanine 0.1 %,L-Histidine 0.21 %,Lactalbumin hydrolysate 0.35 %,Measles Virus 1000 CCID50/0.5ml,Minimum Essensial Medium (MEM) QS QS,Mumps Virus 5000 CCID50/0.5ml,Partially hydrolysed gelatin 2.5 %,Rubella Virus 1000 CCID50/0.5ml,Sorbitol 5 %,Tricine 0.3 %
|
Lyophilized Injection
|
Tanzania
|
TZ14H012
|
Registered/Compliant
|
|
Pneumococcal Polysaccharide 10 Valent Conjugate Vaccine (adsorbeb) (10-Valent) 1 dose
Conjugated to CRM197carrier protein Aluminium (as Aluminium phospahe) 0.125 mg,Saccharide serotype 14 2 mcg,Saccharide serotype 19A 2 mcg,Saccharide serotype 19F 2 mcg,Saccharide serotype 23F 2 mcg,Saccharide serotype 7F 2 mcg,Saccharide serotype 9V 2 mcg,Saccharides for serotype 6B 4 mcg,Saccharides serotypes 1, 5, 9V, 14,19A, 19F, 23F, 7F, 6A 2 mcg,Thiomersal 0.005 %
|
Suspension for injection
|
Tanzania
|
TAN 20 HM 0440
|
Registered/Compliant
|
|
Pneumococcal Polysaccharide Conjugate Vaccine(adsorbed) (10 Valent) 5 dose
Saccharide serotype 1 2 mcg,Saccharide serotype 14 2 mcg,Saccharide serotype 19A 2 mcg,Saccharide serotype 19F 2 mcg,Saccharide serotype 23F 2 mcg,Saccharide serotype 5 2 mcg,Saccharide serotype 6A 2 mcg,Saccharide serotype 6B 4 mcg,Saccharide serotype 7F 2 mcg,Saccharide serotype 9V 2 mcg
|
Suspension for injection
|
Tanzania
|
TAN 20 HM 0439
|
Registered/Compliant
|
|
RABIVAX -S
Purified Rabies Antigen (Rabies virus Pitman-Moore Strain 3218-VERO adapted and grown on vero cells, inactivated by using β - propiolactone) 2.5 IU/ml
|
Lyophilized Injection
|
Tanzania
|
TZ 18 H 0161
|
Registered/Compliant
|
|
REPOITIN 4000
Erythropoietin concentrated solution 4000 IU/0.4
|
Vaccine
|
Tanzania
|
TZ13H251
|
Registered/Compliant
|
|
REPOITIN 4000 (PFS)
EPOETIN ALFA
|
4000/0.4 ML OF API PER UNIT DOSE.
|
Kenya
|
H2015/CTD2779/158
|
Registered
|
|
REPOITIN 4000/1ML (VIAL)
EPOETIN ALFA
|
REPOITIN 4000 : 4000/ 1 ML OF API PER UNIT DOSE.
|
Kenya
|
CTD 2718
|
Registered
|